Pfizer's weight-loss pill won't be in direct competition with Ozempic, says BMO's Evan Seigerman

Pfizer's weight-loss pill won't be in direct competition with Ozempic, says BMO's Evan SeigermanПодробнее

Pfizer's weight-loss pill won't be in direct competition with Ozempic, says BMO's Evan Seigerman

How to be positioned around the vaccine race: Credit Suisse's Evan SeigermanПодробнее

How to be positioned around the vaccine race: Credit Suisse's Evan Seigerman

Novo Nordisk stops Ozempic trial early after signs of early successПодробнее

Novo Nordisk stops Ozempic trial early after signs of early success

Alex Jones, Mandates Are Coming Back! Time to Invest in Pfizer with Alex Jones? PFE Stock AnalysisПодробнее

Alex Jones, Mandates Are Coming Back! Time to Invest in Pfizer with Alex Jones? PFE Stock Analysis

Актуальное